Archive: Company News
Company News: Curetis Reports Results of the Annual General Meeting Held on June 21, 2018
– All proposed AGM resolutions approved by shareholders
Curetis N.V. (the “Company” and together with its subsidiaries “Curetis“), a developer of next-level molecular diagnostic solutions, today reported the results of its Annual General Meeting (“AGM”) held in Amsterdam on June 21, 2018.
Company News: Project Group ProDetekt at Life Science Inkubator (LSI) Sachsen extends patent protection for PRET-ELISA technology to the U.S.
– Solution enables significant optimization of ELISA-based protein analytics
Dresden, Germany, June 21, 2018 – ProDetekt, a start-up project incubated at Life Science Inkubator Sachsen, has been granted a U.S. patent for its proprietary PRET-ELISA technology, which complements the ELISA method used in bioanalytics world-wide. The Company had already received broad European patent protection for its technology in March 2018.
Company News: Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018
Curetis N.V. (the “Company” and, together with Curetis USA Inc. and Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that the Company is going to attend several industry conferences in the third quarter of 2018.
Company News: Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.
— Multiple scientific conference contributions at ASM Microbe highlight benefits of Unyvero LRT
— First commercial evaluation agreements expected in the coming weeks
Curetis N.V. (the “Company” and together with its subsidiaries “Curetis“), a developer of next-level molecular diagnostic solutions, today announced the U.S. commercial launch of its Unyvero sample-to-answer molecular diagnostic system and the Unyvero LRT Application Cartridge for lower respiratory tract infections at the ASM Microbe 2018 Congress in Atlanta, GA, USA (June 7-11). Curetis obtained regulatory clearance for the Unyvero System and Unyvero LRT from the U.S. FDA in April this year.